Paragon 28 (FNA) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 global revenue reached $61.0M, up 19.6%–20% year-over-year, driven by U.S. sales force expansion, international growth, and new product launches.
U.S. revenue was $49.7M (+17.6%–18%), with international revenue at $11.3M (+29.4%), led by the UK, Australia, South Africa, and Spain.
Launched 12 new products YTD, including SMART 28 digital platform and Bun-yo-matic module, supporting balanced growth across all subsegments.
Announced an operational efficiency strategy in August 2024, including workforce reduction, executive compensation realignment, and inventory burndown, targeting up to $8M in annualized savings.
Appointed Chadi Chahine as CFO & EVP of Supply Chain Operations, effective August 5, 2024.
Financial highlights
Gross margin for Q2 2024 was 75.0%, down from 77.3% in Q2 2023, due to higher supplier prices, non-cash inventory expense, and greater international mix.
Adjusted EBITDA loss improved to -$3.0M from -$5.4M in Q2 2023, driven by higher gross profit and cost controls.
Net loss was $13.8M, or $(0.17) per share, compared to $13.2M, or $(0.16) per share, in Q2 2023.
Operating expenses increased 9.7% year-over-year in Q2, but improved as a percent of revenue by 840 basis points.
Ended Q2 with $46.7M–$47M in cash and $50M available credit facility.
Outlook and guidance
2024 revenue guidance narrowed to $249M–$255M, representing 15.1%–17.8% growth, assuming stable FX rates.
Targeting EBITDA positivity in 2025 and cash flow positivity in 2026, supported by operational efficiency initiatives.
Continued momentum expected from new product launches, sales force expansion, and international growth.
Management expects existing cash, borrowing capacity, and revenues to fund operations for at least the next 12 months.
Latest events from Paragon 28
- Strong product innovation and operational discipline position the company for profitable growth in 2025.FNA
Piper Sandler 36th Annual Healthcare Conference9 Jul 2026 - Transformative product launches and digital platforms drive growth and efficiency targets.FNA
Canaccord Genuity 44th Annual Growth Conference2 Feb 2026 - Q3 revenue up 18.1% with first positive Adjusted EBITDA since IPO, but net loss and risks persist.FNA
Q3 202414 Jan 2026 - Robust growth and innovation drive leadership ambitions in the foot and ankle market.FNA
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026